[1]
Alcarraz, C. et al. 2018. Optimal cytoreduction in advanced ovarian cancer treated with dose-dense paclitaxel and carboplatin followed by interval surgery at the peruvian national institute of neoplastic diseases. Revista Peruana de Medicina Experimental y Salud Pública. 35, 1 (Apr. 2018), 46–54. DOI:https://doi.org/10.17843/rpmesp.2018.351.3599.